Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
DPRK strongly condemnded the US strikes on Iran
Iran: Fars News Agency: A woman and her 6-year-old son were killed in an Israeli drone attack on Kermanshah Province
Iran: IRNA: Attack Wave 21 was not carried out, and the operation carried out minutes ago was from Yemen against targets in the occupied territories
Sirens are sounding in Tel Aviv and surrounding areas
Israeli military command: We identified missiles launched from Iran
Tunis: The legitimacy created by World War II is crumbling and the future belongs to free peoples of the world
Tunis: We emphasize that the aggression against Iran should not obscure other ongoing crimes, the first of which is the war of extermination against the Palestinian people
Tunis: International legitimacy does not permit or justify aggression against Iran under any cover or title
Tunisia: Foreign Ministry: We call for an end to the aggression against our sister country, Iran, and we do not limit ourselves to condemning the Zionist and American attacks
Iran: Nur News: An Israeli aerial assault is targeting the region of Parchin, east Tehran

Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk

  • By Al Mayadeen English
  • Source: Agencies
  • 9 Aug 2023 11:10
3 Min Read

This preliminary study implies that this class of weight-loss drugs can impart long-lasting improvements to cardiovascular health.

  • x
  • Photo of the former North American headquarters of Novo Nordisk, Inc., in Plainsboro, N.J. taken on April 24, 2008. (AP)
    Photo of the former North American headquarters of Novo Nordisk, Inc., in Plainsboro, N.J. taken on April 24, 2008. (AP)

In a statement released on Tuesday that sent the firm's shares leaping to a record high, Danish pharmaceutical giant Novo Nordisk claimed that the obesity medicine Wegovy reduces the risk of heart attacks and strokes by a fifth.

Even though it is preliminary, this is the first study to imply that this class of weight-loss drugs, which has garnered substantial public interest, can impart long-lasting improvements to cardiovascular health.

17,604 overweight or obese adults aged 45 participated in the research, and they were randomly assigned to receive either the injectable medication or a placebo over the course of five years.

Strokes, heart attacks, and cardiovascular deaths all decreased by 20%, according to a statement from Novo Nordisk, though the company did not provide a breakdown for each category.

Read: Mediterranean diet can reduce heart attacks, study finds

It added that it planned to file for regulatory approval to broaden the usage for Wegovy in the US and the EU in 2023. The trial's comprehensive results will be published at a scientific meeting later this year.

Related News

Study finds Ozempic good for the heart, not just weight loss

BMI metric has caused 'historical harm': AMA

On Tuesday, Novo Nordisk's stock price increased by more than 17% at market closing in Copenhagen.

"We are very excited about the results," Martin Holst Lange, the company's executive vice president for development said, adding that the drug "has the potential to change how obesity is regarded and treated".

The results were also welcomed by the medical community.

Even though the trials "still need to be confirmed through careful peer review," they still show "the urgent need for patients living with obesity to be offered this effective and safe drug to prevent future disease," according to Simon Cork, senior lecturer in physiology at Anglia Ruskin University, who did not participate in the research.

According to Naveed Sattar, a professor of metabolic medicine, the University of Glasgow, the results "are exciting as preventing heart attacks and stroke with a drug that also lowers weight is very important for many patients." He also did not take part in the research but has previously consulted for Novo Nordisk.

Wegovy and the diabetes medication Ozempic are both produced by Novo Nordisk, the largest producer of insulin in the world. In May, the company reported a 39 percent increase in first-quarter earnings, helped by sales of its obesity therapies.

The European Medicines Agency, which has its headquarters in Amsterdam, announced in mid-July that it was examining data "on the risk of suicidal thoughts and thoughts of self-harm" with respect to three well-known weight-loss medications: Saxenda, Wegovy, and Ozempic. The last two both contain the active ingredient semaglutide.

Among more than a billion people worldwide suffering from obesity, according to the World Health Organization, there is intense competition among pharmaceutical companies to develop effective therapies.

  • overweight
  • stroke patients
  • Denmark
  • heart failure
  • obesity
  • Novo Nordisk

Most Read

Iran launches 9th wave of Op. True Promise 3, destroys IOF air defense

Iran launches 9th wave of Op. True Promise 3, destroys IOF air defense

  • MENA
  • 17 Jun 2025
Rescue team work at the site where a missile launched from Iran struck Tel Aviv, Israel, Monday, June 16, 2025 (AP)

Wave 12 of Operation True Promise 3 launched, Sejjil deployed: IRGC

  • Politics
  • 18 Jun 2025
Israeli workers survey the site where a missile launched from Iran struck in Haifa on Sunday, June 22, 2025. (AP)

True Promise 3, wave 20: 40 missiles launched, Kheibar-Shekan in first

  • Politics
  • 22 Jun 2025
Iran launches missile barrage to Tel Aviv, casualties reported

True Promise 3, wave 14: Tel Aviv targeted, casualties reported

  • Politics
  • 19 Jun 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Secretary of Iran's Supreme National Security Council Ali Shamkhani, speaks with then-Syrian Prime Minister Imad Khamis in a meeting in Tehran, Iran, Tuesday, January 17, 2017 (AP)
Politics

Iran holds the initiative after nuclear strikes, Shamkhani says

Blood stains a religious painting inside Mar Elias Church, where a suicide bomber detonated himself in al-Dwela, on the outskirts of Damascus, Syria, on Sunday, June 22, 2025 (AP)
Politics

UN, regional governments condemn Damascus church bombing

A B-2 bomber arrives at Whiteman Air Force Base Missouri, Sunday, June 22, 2025, after returning from a massive strike on Iranian nuclear sites on Saturday (AP)
Politics

Israeli media: US-Israeli strike on Iran failed to end war

China UN Ambassador Fu Cong addresses the United Nations Security Council, Monday, March 24, 2025. (AP Photo/Richard Drew)
Politics

China slam US strikes on Iran nuclear sites

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS